The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consolidation nivolumab/ipilimumab versus nivolumab following concurrent chemoradiation in patients with unresectable stage III NSCLC: A planned interim safety analysis from the BTCRC LUN 16-081 trial.
 
Melissa Yan
No Relationships to Disclose
 
Greg Andrew Durm
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Hirva Mamdani
Consulting or Advisory Role - AstraZeneca; Tempus
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Takeda
 
Vinicius Ernani
No Relationships to Disclose
 
Salma K. Jabbour
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Jarushka Naidoo
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Borys Hrinczenko
Research Funding - Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Merrimack (Inst); Tragara (Inst)
Patents, Royalties, Other Intellectual Property - U.S Patent Application No. 15/885,024, "Electrode and Sensor Apparatus and Related Methods for Detection of Nitric Oxide and Peroxynitrite", inventors Greg M. Swain, Serban F. Peteu, Borys W. Hrinczenko. Filed with the U.S. Patent & Trademark Office (USPT (Inst)
 
Ticiana Leal
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech; Genentech; InvisionFirst Lung; Merck; Merck; Novocure; Takeda; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics; Takeda; Takeda
 
Lawrence Eric Feldman
Research Funding - BrightPath Biotheraputics; E.R. Squibb Sons, LLC (Inst); Genentech (Inst); Merck (Inst); Roche (Inst); Soligenix (Inst)
 
Goetz H. Kloecker
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis; Sanofi
Consulting or Advisory Role - Lilly; Novartis
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Novartis
 
Naomi Fujioka
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst)
 
Mary J. Fidler
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Genentech; Genentech (I); Guardant Health; Guardant Health; Rakuten Medical (Inst)
Speakers' Bureau - Genentech; Merck
Research Funding - AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
Other Relationship - BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals